Resonant Molecular Signaling: From Theory to Practice
Good health is dependent on the appropriate transfer of information within and between cells. The informational and molecular disharmonies associated with disease can be reversed using appropriate therapeutic signals that stimulate the return to the normal state without adverse effects. One such signal molecule, SLO, has demonstrated clinical utility in a broad spectrum of indications that would at first glance appear to be unrelated. The underlying common thread that links these disorders is representative of the targets to which resonant molecular signals are directed.
Bio: John McMichael received his PhD in immunology and virology from Oregon State, and did post-doctoral work at the Wistar Institute. He was head of the infectious disease section of one of the country’s largest private veterinary research and diagnostic labs. A former professor, he is currently president of Beech Tree Labs, Inc., a private research and development lab focused on discovery and early development of novel therapeutic agents for the human and veterinary health care markets. John is married, has two grown children, and lives on a working upstate New York farm.